INTRODUCTION
Invasion is a fundamental step in tumor progression and a driving force for metastasis. Although invasion is commonly conceptualized as a single-cell process, the majority of solid tumors display features of collective invasion in which cells invade cohesively as a multicellular unit (Friedl et al., 2012; Leighton et al., 1960) . A central problem in collective invasion is how a group of adherent epithelial cancer cells acquires motile invasive behavior (Friedl and Gilmour, 2009; Gray et al., 2010; Polyak and Weinberg, 2009) .
One solution is for cancer cells to rely upon the motility of migratory stromal cells, such as fibroblasts (Gaggioli et al., 2007) or macrophages (Condeelis and Pollard, 2006; DeNardo et al., 2009 ). However, mammary tumors also contain multiple subpopulations of tumor cells with distinct genotypic and phenotypic characteristics. Importantly, this cellular heterogeneity is associated with differences in metastatic potential and therapeutic response (Almendro et al., 2013; Fidler, 2003) . It remains unclear how these subpopulations of cancer cells contribute to collective invasion.
Clinically, the transition from in situ to invasive breast cancer correlates with a strong reduction in overall survival, but the molecular basis of this transition has remained elusive (Polyak, 2010) . The challenge of transitioning to a motile phenotype is particularly acute in mammary luminal epithelial cells, as these cells are normally connected by extensive intercellular junctions and display less spontaneous motility than myoepithelial cells in real-time analyses (Ewald et al., 2008) . Consistent with this concept, luminal breast cancers have a more favorable average prognosis, but 8%-21% of cases eventually metastasize to liver, lung, or brain (Kennecke et al., 2010) . Furthermore, luminal breast cancer cell lines are weakly invasive in 2D culture compared to basal subtypes (Neve et al., 2006) .
We hypothesize that breast tumors accomplish collective invasion through cell-cell interactions among functionally distinct epithelial cancer cells within the primary tumor. To test this hypothesis, we developed 3D organoid assays to identify the most invasive cancer cells within a primary tumor in an unbiased fashion. In the present study, we applied these assays to demonstrate that the cells leading collective invasion are molecularly and behaviorally distinct from the bulk tumor cells and display a conserved, basal epithelial gene expression program.
RESULTS

An Ex Vivo 3D Culture Assay Identifies Invasive Cells within Primary Tumors
We developed a 3D primary culture model (Nguyen-Ngoc et al., 2012 ) that enabled us to observe cell behaviors during collective invasion and to interrogate the molecular phenotype of the most invasive cells ( Figure 1A ). Briefly, we isolate fresh primary tumors and use a combination of mechanical disruption and enzymatic digestion to generate ''tumor organoids.'' Tumor organoids are composed of 200-1,000 adherent tumor cells and reflect the cellular heterogeneity present in the primary tumor. To study collective invasion, we cultured tumor organoids in 3D collagen I gels, a model for the microenvironment surrounding invasive breast cancers (Conklin et al., 2011; Nguyen-Ngoc et al., 2012; Paszek et al., 2005; Provenzano et al., 2008; Wolf et al., 2009) .
We first characterized invasion in organoids derived from a genetically engineered mouse model of breast cancer in which the mouse mammary tumor virus long terminal repeat drives expression of the polyoma virus middle T oncogene (MMTVPyMT) (Guy et al., 1992a) . MMTV-PyMT mice develop highly invasive mammary tumors that metastasize spontaneously to the lung (Lin et al., 2003) . By gene expression profiles, MMTVPyMT tumors cluster with the aggressive luminal B subtype of human breast cancer (Herschkowitz et al., 2007) . Tumor organoids isolated from this model progressively extended multicellular strands of cancer cells into the collagen I over 48-72 hr ( Figure 1B and Movie S1 available online). Because the cells leading these invasive strands were highly protrusive and migratory, we refer to them as ''invasive leader cells'' ( Figure 1B, right) . 
Invasive Leader Cells Are Molecularly Distinct and Express Basal Epithelial Markers
We were able to determine the molecular phenotype of invasive leader cells unambiguously due to their position at the front of invasive strands and their distinct protrusive morphology. Our analysis defined four molecular features of leader cells in this luminal mouse model. First, leader cells preferentially expressed multiple basal epithelial markers, including cytokeratin-14 (K14), p63, P-cadherin, and cytokeratin-5 (K5) (Figures 1C-1G ). Among these markers, K14 was the most frequently associated with leader cells (94% of leaders, n = 1,523 leaders, from 10 mice, CI [93%-95%]). Second, leader cells coexpressed markers of luminal epithelium, including K8, K18, and E-cadherin (Figures 1G and S1A-S1C). However, whereas basal markers were preferentially expressed in leader cells, K8 and E-cadherin also strongly stained the noninvasive K14À core of cells within the tumor organoid (Figures S1A and S1C). Third, leader cells typically did not express markers of smooth muscle contractility, such as SMA, MYH11, and CNN1 (Figures 1G, and S1D, and S1E) and did not contract in response to the hormone oxytocin, which induces smooth muscle contractility (Figures S1F and S1G) . Because the smooth muscle program is a defining feature of myoepithelial cells in the normal mammary gland, we conclude that invasive leader cells are distinct from myoepithelial cells. Fourth, leader cells did not typically express Twist, Slug, or vimentin ( Figure S1H ), which are common markers of a molecular epithelial-mesenchymal transition (EMT). Finally, leader cells retained membrane localized E-cadherin at sites of cell-cell contact with follower cells ( Figure S1C , blue arrows). Taken together, our observations reveal that invasive leader cells in this luminal breast cancer model are molecularly distinct from bulk tumor cells and preferentially express K14 and other basal epithelial markers.
K14+ Cells Are Enriched at the Invasive Border in Primary Tumor and in Lung Metastases
We next asked whether K14+ cells also led collective invasion in vivo in this luminal model. To address this question, we optically reconstructed large regions of the tumor-stromal border from fixed sections of intact tumors. K14+ cells were concentrated at tumor-stromal borders (n = 9 reconstructed tumors from 8 mice; Figure 2A ) and led multicellular invasive strands into the adjacent muscle (Figures 2A and 2B and Movie S2) . As in 3D culture, K14+ cells were negative for SMA and coexpressed luminal K8 ( Figures 2B and S2A) . Thus, K14+ cells lead collective invasion in 3D culture and in vivo.
We next asked what fraction of collective invasion in vivo was led by K14+ cells. We employed an orthotopic transplant model to mark donor-derived tumor cells unambiguously. We transplanted MMTV-PyMT mammary tumor organoids coexpressing a red fluorescent reporter (mTomato) into the cleared mammary fat pads of nonfluorescent congenic hosts (FVB) and identified invasive units at the tumor-stromal border, blind to K14 expression ( Figures 2C and 2D ). These invasive units included multicellular groups of cells connected to the main tumor mass, which we defined as invasive strands, and groups of cells unconnected from the main tumor mass, which we defined as tumor nests ( Figure 2D, middle) . We then classified each invasive unit-in the case of strands, we asked whether the leader cells were K14+, and in the case of nests, we asked whether any cell in the group was K14+. By this measure, we observed that 88% of invasive strands and 80% of tumor nests were K14+ ( Figure 2D, right) Figure S2 . (legend continued on next page)
we systematically quantified the distance of K14+ and K14À cells from the tumor-stromal border in large optically reconstructed montages ( Figures S2E-S2G ). We observed strong enrichment for K14+ cells in the first 100 mm from the stromal border, whereas K14À cells were relatively uniformly distributed (n = 5 montages from 4 tumors; Figure S2H ). We conclude that K14+ cancer cells are strongly enriched at the tumor-stromal interface and lead the majority of collective invasion in vivo. Because MMTV-PyMT tumors develop metastases with high penetrance, we next quantified the K14 status of their lung metastases. Although K14 was absent in normal lung parenchyma, we observed K14 staining in >88% of metastatic lesions, from micrometastases up to large, 500 mm lesions ( Figures 2E-2H ). In contrast, K14+ cells constituted only a small percentage of the total cell population in the primary tumor (1.4% ± 0.2% by fluorescence-activated cell sorting [FACS] , n = 3 mice; Figure S2D) . Consistent with their phenotype in the primary tumor, K14+ metastases were negative for SMA in both micrometastatic and large metastatic lesions (Figures S2B and S2C) . We conclude that, although K14+ cells are rare in the primary tumors of this luminal breast cancer model, they are strongly enriched in lung metastases.
K14+ Cells Lead Collective Invasion across Multiple Mouse Models of Breast Cancer
To test the generality of our observations, we next characterized invasion in two additional genetically engineered mouse models of breast cancer: MMTV-Neu, a model of HER2+ luminal breast cancer, and C3(1)/Tag, a model of basal breast cancer (Guy et al., 1992b; Maroulakou et al., 1994) . Tumor organoids isolated from these models displayed pronounced differences in the morphologic patterns and timing of invasion in 3D culture (Figures 3A and 3B and Movie S3) . MMTV-Neu tumor organoids had the fewest leader cells, MMTV-PyMT organoids had an intermediate number, and C3(1)/Tag tumor organoids had the most leader cells ( Figures 3C and 3D ). Despite these differences in the frequency of invasion, >80% of leader cells in all three models were K14+ ( Figure 3E ). Similarly, the majority of K14+ leader cells coexpressed luminal K8 but did not express SMA in all three models ( Figures 3B, 3E , S3A, and S3B).
K14+ Cells Lead Collective Invasion in Primary Human
Breast Tumors in 3D Culture and In Vivo To validate our observations from mouse models, we next characterized invasive leader cells in fresh human breast tumor specimens. We isolated organoids from primary tumor tissue obtained at initial breast surgery (n = 10; Figure 3F ) using established protocols (Nguyen-Ngoc et al., 2012) . We classified each specimen using surrogate immunohistochemistry definitions (Goldhirsch et al., 2013) . In total, there were nine luminal breast cancers, five of which were luminal B. In each case, human tumor organoids invaded into collagen I matrix ( Figure 3F and Movie S3). Although the numbers of invasive strands and disseminated cells varied among tumor samples, >86% of leaders expressed K14 across all samples ( Figures 3F, 3G , and S3E). K14+ cells typically coexpressed nuclear p63 ( Figure S3C ) and typically did not express SMA (Figures 3F and S3E) . A subset of K14+ cells was also positive for luminal K8 and K18 (Figure S3D) . Together, these data demonstrate that the cells that lead invasion in 3D culture express basal epithelial markers across multiple mouse models of breast cancer and in primary human breast tumors.
We therefore hypothesized that K14+ cells would lead collective invasion in primary human breast tumors in vivo. We first examined fixed sections from intact tumor specimens corresponding to three cases from 3D culture. We observed that K14+ cells led collective invasion in each case ( Figure S3F ). We next assayed for K14+ cells in archival specimens of primary breast tumors (n = 39 specimens) from multiple subtypes of human breast cancer. Using consensus guidelines, we then assigned these specimens to breast cancer subtypes based on their ER, PR, HER2/Neu, and Ki-67 status, as assayed by immunohistochemistry (Goldhirsch et al., 2013 ). There were 16 luminal A cases, 17 luminal B cases (including 4 cases with HER2+ disease), and 6 triple-negative breast carcinomas (Figure 3I ). We stained these samples for K14 using immunohistochemistry and classified their intensity to three levels: low (+), medium (++), and high (+++) ( Figure S4A ).
We observed strong K14 staining (CK3) in collective invasive fronts in luminal A, luminal B (both HER2À and HER2+), and triple-negative breast cancers ( Figures 3H, 3J , and S4D-S4G). Breast cancer subtype was not statistically significantly associated with K14 staining intensity (Fisher's exact test, (D) The percentage of invasive tumor organoids from the three mouse models in (A) as a function of time in culture (in hr). Onset of invasion was defined as the first instance of protrusive cell motility into collagen I matrix. n = 22-70 tumor organoids per mouse model. (E) Frequency of leader cells expressing K14 or SMA in MMTV-Neu or C3(1)/Tag tumor organoids. 95% confidence intervals for each proportion denoted in parentheses. (F) Time-lapse DIC microscopy of a human luminal breast tumor organoid embedded in collagen I matrix (sample S4). White bar, leader cell. At right, micrograph of tumor organoid from same tumor specimen, stained for K14, SMA, and F-actin. See also Movie S3. (G) Pathologic characteristics of harvested human breast tumors, including stage, grade, ER status, PR status, HER2/Neu status, Ki-67 percentage, and the measured frequency of K14+ leaders. 9 of 10 tumors were ER-positive luminal breast tumors, with ER positivity ranging from 20%-100%. The breast cancer subtype was determined using surrogate immunohistochemistry definitions (Goldhirsch et al., 2013) . (H) Representative micrograph of a K14+ collective invasion front from an archival specimen classified as luminal B.
(I) The distribution of cases according to breast cancer subtype assigned using surrogate IHC subtype definitions. n = 39 cases in total. (J) The frequency of cases with low (+), medium (++), or high (+++) K14 staining stratified by IHC-defined breast cancer subtype. K14 intensity was scored as in Figure S4A . p = 0.11). We also stratified samples by histologic grade (Figure 3K ). In general, higher histologic grade was associated with higher K14 staining intensity ( Figure 3L , Fisher's exact test, p < 1 3 10 À4 ). However, even among luminal B tumors with high grade (grade 3), we identified cases with low, medium, and high K14 staining ( Figure S4A ). We observed three distinct patterns of K14 staining in human tumors: cytoplasmic staining, cytoskeletal staining with intense staining bundles of K14, and a border-enriched pattern, in which staining appeared specific to cells at the border of the collective invasion front ( Figure S4B ). The triple-negative breast cancers showed a statistically significant increase in cytoskeletal staining pattern relative to luminal tumors ( Figure S4C ; Fisher's exact test, p < 0.01). Together, these data demonstrate that K14 is expressed in collective invasion fronts across the major subtypes of human breast cancer.
Luminal Tumor Cells Acquire Markers of Basal Differentiation
To address how K14+ leaders are generated, we asked when K14 was expressed in 3D culture of MMTV-PyMT tumor organoids. Consistent with the low in vivo frequency of K14+ cells in this luminal mouse model, tumor organoids were initially K8+, with few K14+ cells. During the first 48 hr of culture, the number of K14+ cells and p63+ cells in tumor organoids increased significantly ( Figures 4A-4D , S5A, and S5B). This expansion in basal marker positive cells coincided closely in time with the onset of collective invasion ( Figures 4E and S5C ). K14+ and p63+ cells were most frequently observed on the basal surfaces of tumor organoids in contact with the extracellular matrix (ECM). Thus, tumor organoids start 3D culture primarily luminal in character and subsequently expand a population of cells with basal differentiation markers. One possible cellular mechanism for the expansion of K14+ cells is cell proliferation. However, the number of mitotically active (pH3+) K14À cells was significantly greater than the number of mitotically active K14+ cells during the first 2 days of culture (Figures S5D and S5E) . Furthermore, treatment with aphidicolin blocked mitosis completely but did not prevent an increase in K14+ cells (Figures 4F-4H) . We conclude that proliferation is not required for acquisition of a K14+ cell phenotype.
Alternatively, luminal tumor cells may convert directly from K14À to K14+ states. To test this hypothesis directly, we generated MMTV-PyMT mice carrying a K14 promoter biosensor in which GFP reports on K14 gene expression (Vaezi et al., 2002) . In these tumor organoids, we observed individual cells at the basal surface transition from K14À to K14+ states ( Figure 4I , cross-sectional view, and S5F, en-face, and Movie S4; n = 22 movies). Following phenotypic conversion, the newly K14+ cells dynamically extended and retracted membrane protrusions into the matrix (n = 149 movies) and led migration of trailing GFPÀ cells (n = 70 movies; Figure 4J and Movie S4). Consistent with these data in mouse, we observed that organoids derived from multiple primary human breast tumors similarly expanded their fraction of K14+ and p63+ cells (Figures S5G-S5I ). Taken together, these data reveal that the invasive leader phenotype is a differentiation state exhibited by cancer cells, not a fixed lineage.
K14+ Cells Acquire Leader Cell Behaviors Specifically in Collagen-I-Rich Local Microenvironments
We previously demonstrated that ECM composition strongly regulates tumor invasion (Nguyen-Ngoc et al., 2012) . Organoids isolated from the same tumor but allocated to different ECMs robustly invaded when cultured in collagen I, but not when cultured in basement membrane gels (Matrigel). We therefore hypothesized that different ECM environments might have a differential capacity to induce the basal gene expression characteristic of invasive leader cells.
To test this hypothesis, we cultured MMTV-PyMT tumor organoids in 3D Matrigel. Although tumor organoids were noninvasive in Matrigel ( Figures S6A-S6C) , we still observed a robust increase in the number of K14+ tumor cells. At day 0, there were few K14+ cells, but by day 4, 99% of tumor organoids had basal K14+ staining ( Figures 5A and 5B) . As in collagen I, Matrigel-embedded tumor organoids expressed nuclear p63 and P-cadherin specifically in basally located cells in contact with ECM and did not express SMA ( Figures 5C, 5D , and S6D). Consistent with these results, we also observed phenotypic conversion in K14-GFP;PyMT tumor organoids cultured in Matrigel ( Figure S6E and Movie S5; n = 5 movies). Taken together, these data demonstrate that induction of the basal epithelial program does not require collagen I and occurs in diverse ECM microenvironments.
If phenotypic conversion induces a stable change in invasive potential, then switching to an invasive microenvironment should induce an acute change in K14+ cell behavior. To test this hypothesis, we conducted a matrix-swapping experiment. We cultured PyMT tumor organoids in 3D Matrigel for 4 days, liberated organoids from the gel, and re-embedded them in collagen I. Under these conditions, there was rapid collective invasion from the basal layer within 12 hr ( Figures S6F and S6G and Movie S6; n = 14 movies). In response to collagen I matrix, individual K14+ cells at the basal surface became protrusive and subsequently initiated collective invasion ( Figure S6G, insets) . These findings show that phenotypic conversion and collective invasion are distinct steps and that the latent invasive potential of K14+ cells is only converted to invasive cell behaviors in specific tumor microenvironments.
In vivo, we observed that, although K14+ cells led collective invasion, there were also K14+ cells with noninvasive morphology (Figure 2A ). These findings raised the question of which factors in vivo distinguish K14+ cells that manifest invasive morphology from those that do not. Because the local ECM context within a primary tumor is heterogeneous, we hypothesized that differences in invasive morphology in vivo would correlate with differences in ECM context. Accordingly, we assayed fibrillar collagen density in fixed thick tumor sections by second harmonic generation (SHG) and collagen IV density by immunofluorescence. Areas were classified as having either invasive or noninvasive morphology based on the protrusive morphology of the K14+ cells in the region (Figures 5E and  5F ). Invasive regions were associated with an $8-fold increase in median collagen I fiber density relative to noninvasive regions ( Figure 5G ). In contrast, collagen IV, a component of basement membrane and Matrigel, was observed at comparable levels in both invasive and noninvasive regions ( Figure 5H ). Taken together, our data demonstrate that 3D Matrigel and 3D collagen I ECM microenvironments induce distinct cell morphologies similar to those observed in specific regions of primary tumors in vivo and suggest that K14+ cells in vivo acquire leader cell behaviors specifically in collagen-I-rich local microenvironments.
Basal Epithelial Genes K14 and p63 Are Required for Collective Invasion in 3D Culture
We next asked whether expression of basal epithelial genes by leader cells is functionally required for collective invasion. Accordingly, we developed protocols for efficient lentiviral transduction of primary tumor organoids. We tested five different small hairpin RNAs (shRNAs) targeting K14 and p63 and determined the two hairpins with the highest knockdown efficiency by western blotting (Figures S7A and S7B) . As a control, we used a hairpin that targets luciferase (Luc-kd).
To assess the requirement for K14 in collective invasion, we cultured Luc-kd, K14-kd1, and K14-kd2 tumor organoids in 3D collagen I and observed them by time-lapse differential interference contrast (DIC) microscopy. Control Luc-kd organoids strongly expressed K14 and invaded vigorously into collagen I matrix ( Figures 6A-6C and Movie S7). In contrast, both K14 expression and collective invasion were markedly reduced in K14-kd organoids ( Figures 6A, 6B, 6D , and 6F). Although K14-kd tumor organoids generally lacked multicellular invasive strands, we still observed subcellular protrusions extending from K14-kd organoids ( Figure 6D , red arrows, and Figure S7C ). We next infected organoids with lentiviruses encoding both K14-shRNA and GFP to label K14-kd cells in real time. By tracking infected organoids at single-cell resolution, we observed individual K14-kd cells that were protrusive and motile ( Figure 6H ). Thus, we conclude that K14 is dispensable for subcellular protrusions but is required for the transition to persistent collective invasion.
We next examined the phenotypic consequences of p63 knockdown (p63-kd1 and p63-kd2) in PyMT primary tumor organoids cultured in collagen I ( Figures 6A, 6B, 6E , and 6G). We observed a strong reduction in p63 protein levels and in collective invasion in p63-kd organoids ( Figures 6E, 6G , and S7D). However, compared with K14-kd organoids, p63-kd organoids had fewer protrusive cells and more rounded cell borders (Figures 6E and S7C and Movie S7) . Because knockdown with p63 hairpin abrogated collective invasion but yielded only a partial reduction in K14, these data suggest that p63 has essential K14-independent functions in collective invasion. In aggregate, these data demonstrate that multiple basal epithelial genes expressed by leader cells are individually required for collective invasion in 3D culture. Furthermore, these data show that basal epithelial genes are required for collective invasion in a luminal mouse model of breast cancer, despite being expressed in only a small minority of the tumor cells.
In Vivo Knockdown of K14 Disrupts Collective Invasion at the Tumor-Stromal Border
We next sought to test the requirement for K14 in collective invasion in vivo. We isolated tumor organoids from fluorescently labeled advanced carcinomas (mTomato+; MMTV-PyMT), transduced them with Luc-kd, K14-kd1, or K14-kd2 lentivirus, and then orthotopically transplanted the transduced organoids into the cleared mammary fat pads of nonfluorescent congenic hosts ( Figure 7A ). Although tumor growth appeared similar, we observed strong differences in collective invasion at the tumorstromal border. In Luc-kd tumors, cells at the tumor stromal border strongly expressed K14 and organized many K14+ invasive strands and nests of cells ( Figure 7B ). In contrast, in K14-kd1 tumors, we observed large regions in which the tumor stromal border was K14À and lacked either invasive strands or nests ( Figures 7C and 7D ). The K14À regions instead displayed borders with a rounded morphology ( Figures 7C and 7D) . Furthermore, whereas fibrillar collagen was associated with collective invasion in control tumors ( Figure 5E ), in K14-kd1 tumors, this association was disrupted. Within K14-kd1 tumors, we observed noninvasive borders that were both K14À and surrounded by dense fibrillar collagen ( Figure 7F ). To quantify the differences in collective invasion between knockdown conditions, we determined the number of invasive strands and nests per tumor section. The number of collective invasive units per section was significantly reduced in K14-kd1 tumors relative to Luc-kd control tumors ( Figure 7D ). Consistent with the less efficient knockdown of K14-kd2 observed by immunofluorescence and western blotting, we observed a qualitatively similar reduction in invasive units in K14-kd2 tumors ( Figures 7D and 7E) . The residual invasion observed in both K14-kd1 and K14-kd2 tumors was predominantly K14+ and was concentrated in discrete K14+ tumor foci ( Figures 7E and 7G ). These data demonstrate the presence of residual tumor cells competent to express K14 and suggest that, despite puromycin selection prior to transplantation, K14-competent cells preferentially expanded in vivo.
Together, these data demonstrate (1) that K14 is required in vivo for collective invasion at the tumor-stromal border, (2) that elevated collagen I is not sufficient to induce collective invasion in vivo in the absence of K14 expression, and (3) that targeting a basal invasive program expressed in a small minority of tumor cells is sufficient to disrupt the invasive process in an advanced carcinoma.
DISCUSSION
The transition to invasive behavior in epithelial cancer cells is a critical step in metastasis, yet both the cellular and molecular basis of this transition is incompletely understood. An important challenge is that primary tumors are complex heterogeneous tissues containing phenotypically and genetically distinct cancer cell subpopulations interacting with an altered extracellular matrix and diverse stromal cells (Almendro et al., 2013; Egeblad et al., 2010a Egeblad et al., , 2010b Fidler, 2003; Weigelt and Bissell, 2008) . It is important to reduce this complexity to specific molecular regulators of tumor cell behavior in order to identify targets for therapeutic intervention.
To accomplish this goal, we developed a general strategy for identifying the most invasive cells in a primary epithelial tumor. We then applied this strategy and discovered that the most invasive cancer cells are behaviorally and molecularly distinct from bulk tumor cells. Importantly, the invasive leader cells expressed basal epithelial genes, including K14 and p63, across mouse models of breast cancer and in diverse human breast tumors. Cells with this phenotype led the majority of collective invasion in vivo and were strongly overrepresented in lung metastases. We therefore have exploited our assays to resolve the heterogeneous cancer cell populations within the primary tumor into functional classes based on their invasive behavior. We then leveraged this understanding to establish the requirement for K14 and p63 for collective invasion in primary cells derived from poorly differentiated carcinomas.
Previous studies have shown that heterotypic epithelial-stromal interactions contribute to cancer invasion in diverse malignancies (Condeelis and Pollard, 2006; Gaggioli et al., 2007) . Our data establish the importance of heterotypic epithelialepithelial interactions between different cancer cell subpopulations in collective invasion. Importantly, although invasive leader cells were highly protrusive and migratory, they retained characteristically epithelial expression of cell adhesion proteins (e.g., E-cadherin) and intermediate filament proteins (e.g., K14, K8) during invasion.
K14 expression also marks other highly migratory epithelial cell populations. During development, the migratory cells of the normal mammary embryonic placode are K14+K8+SMAÀ (Moumen et al., 2011; Sun et al., 2010) . Similarly, the highly invasive rat breast cancer MTLn3 cell line is K14+K8+, whereas noninvasive MTCs do not express these markers (Lichtner et al., 1991) . Likewise, highly invasive human breast cancer cell lines MDA-MB-468, MDA-MB-436, and BPLER are K14+K18+, whereas cell lines with low invasive potential, such as MCF-7, T47D, and ZR75 express a pure luminal phenotype (Gordon et al., 2003; Petrocca et al., 2013) . Experimental models suggest that basal breast cancers arise from luminal progenitors and that mutations in genetic drivers of breast cancer, such as BRCA1, can shift luminal progenitors toward basal differentiation (Lim et al., 2009; Molyneux et al., 2010) . Consistent with these observations, a number of pathologic studies have shown that basal cytokeratins, including K14, are associated with poor patient prognosis, early relapse, and reduced overall survival (de Silva Rudland et al., 2011; Gusterson et al., 2005; Laakso et al., 2006; Malzahn et al., 1998) . Our study provides a biological basis 
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Luc K14 K14 MMTV-PyMT in 3D Culture Inset shows that protrusive behavior is intact. In p63 shRNA transduced organoids, tumor organoids do not invade collectively (E). Inset shows lack of protrusions and rounded cell borders in p63-kd1 tumor organoids. See Movie S7.
(F and G) The number of collective invasive strands in Luc shRNA, K14-shRNA kd1 and kd2, and p63-shRNA kd1 and kd2 transduced organoids was determined from time-lapse movies. The maximal number of invasive strands at any time was determined. n = 170 movies for Luc shRNA from 7 independent experiments. n = 133 movies for K14 shRNA kd1 from 7 independent experiments. n = 36 movies for K14 shRNA kd2 from 3 independent experiments. n = 90 movies for p63
(legend continued on next page) for these findings, namely that K14 marks a subpopulation of tumor cells capable of initiating collective invasion, a critical step in metastatic progression. Importantly, we directly observed phenotypic conversion of K14À luminal tumor cells to K14+ cells with invasive potential. We previously demonstrated that collective invasion is strongly regulated by the composition of the local extracellular matrix (Nguyen-Ngoc et al., 2012) . In the present study, we demonshRNA kd1 from 5 independent experiments. n = 42 movies for p63 shRNA kd2 from 3 independent experiments. Data are presented as boxplots. p values were determined by two-sided t test. **p < 0.001. ***p < 1 3 10 À10 .
(H) Time-lapse sequence of a representative tumor organoid transduced with lentiviral particles encoding for dual expression of K14-shRNA and GFP. GFP is shown in false color purple. Arrows, individual GFP+ (and K14-shRNA-expressing) protrusive cells. Scale bars, 20 mm in (A), 50 mm in (C-E), and 10 mm in (H). See also Figure S7 . Luc K14 K14 Figure 2E . p values were determined by two-sided t test.
(E) Frequency of invasive units expressing K14 in Luc-kd and K14-kd tumor sections. 95% confidence intervals for each proportion were denoted in parentheses.
(F) Representative micrograph of K14-kd1 tumorstromal border stained for K14 and assayed for fibrillar collagen by SHG. mT+ regions (in red), tumor-derived cells.
(G) Micrograph of a K14-kd1 tumor stained with K14, demonstrating K14+ and K14À tumor foci. The micrograph represents a z-projection of more than 40 mm. Scale bars represent 100 mm in (B and C), 40 mm in (F), and 1,000 mm in (G).
strated that the basal invasive program can be induced in diverse ECM microenvironments. However, consistent with our prior study, basal gene expression was only associated with invasive cell behaviors and morphologies in collagen-I-rich microenvironments in 3D culture and in vivo.
In our study, we established that the basal epithelial intermediate filament cytoskeleton is specifically required for collective invasion in cancer. Our data suggest that actin-based subcellular protrusions and multicellular collective invasion can be uncoupled and have distinct cytoskeletal requirements. The precise mechanism by which cytokeratin 14 regulates collective invasion, be it directly modifying the tensile strength and viscoelastic properties of the cell (Yamada et al., 2002) , regulating cell-cell adhesion (Weber et al., 2012) , or by signal transduction mechanisms independent of their mechanical properties (Kim et al., 2006) , remains unclear and warrants further study. Because cells with basal differentiation are found in many epithelial organs, our findings may also have implications for invasion in other solid tumors.
EXPERIMENTAL PROCEDURES Mouse Lines and Breeding
Mice used in this study were backcrossed onto and maintained on the FVB/n background in a specific pathogen-free facility. Animal protocols were approved by the Johns Hopkins IACUC. FVB/N-Tg(MMTV-PyVT)634Mul/J (MMTV-PyMT) (Guy et al., 1992a) , FVB/N-Tg(MMTVneu)202Mul/J (MMTV-Neu) (Guy et al., 1992b) , FVB-Tg(C3-1-TAg)cJeg/JegJ (C3(1)/Tag) (Maroulakou et al., 1994) , and B6.129(Cg)-Gt(ROSA)26Sortm4(ACTBtdTomato,-EGFP)Luo/J (mT/mG) (Muzumdar et al., 2007) mice were obtained from the Jackson Lab. K14-GFP-actin mice (Vaezi et al., 2002) were a generous gift from Elaine Fuchs (Rockefeller University). For confocal timelapse experiments, MMTV-PyMT mice were crossed with mT/mG mice and/ or K14-GFP-actin mice.
Analyses of Fresh Primary Human Tumors
Primary breast cancers were acquired in accordance with IRB exempt protocols NA_00052607 and NA_00077976 (Nguyen-Ngoc et al., 2012) . In brief, each tumor sample was deidentified prior to receipt with limited prespecified clinical information provided with each sample. The tumor sample was kept in cold Dulbecco's modified Eagle's medium (DMEM) when in transit. The tumor sample was rinsed with antibiotic wash, minced, and then digested in collagenase with or without trypsin. Tumor organoids were treated with DNase and separated out by differential centrifugation at 1,500 rpm 3 4-6 spins. Tumor organoids were then allocated to either Matrigel or 3D collagen I and cultured in human mammary epithelium medium containing insulin, EGF, hydrocortisone, and cholera toxin. Medium was replaced every 3 to 4 days.
Statistics
Statistical analysis was conducted using R. For all boxplots, the whiskers represent the 5 th and 95 th percentiles. All tests used and p values are specified in the figure legends. p < 0.05 was considered significant. Additional materials and methods, including isolation of tumor organoids, antibodies, and staining procedures used, are described in the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven figures, and seven movies and can be found with this article online at http://dx. doi.org/10.1016/j.cell.2013.11.029.
